Eclipsebio's eCOMPASS™ platform integrates AI-optimized RNA design (eNAVIGATE™), in-house prototyping at R&D scale, and deep sequencing-based characterization (eMERGE™) into a single iterative ...
With $1.3 billion in fresh capital — which is split between a $591 million early-stage incubation fund and one more oriented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results